Chemosensitizer and docetaxel-loaded albumin nanoparticle: overcoming drug resistance and improving therapeutic efficacy

Improved oral bioavailability and therapeutic efficacy of erlotinib through molecular complexation with phospholipid

(2017) Chander Parkash Dora et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Adenosine conjugated lipidic nanoparticles for enhanced tumor targeting

(2015) Rajan Swami et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

p-Hydroxy benzoic acid-conjugated dendrimer nanotherapeutics as potential carriers for targeted drug delivery to brain: an in vitro and in vivo evaluation

(2015) Rajan Swami et al.   JOURNAL OF NANOPARTICLE RESEARCH

Enhanced Antitumor Efficacy and Reduced Toxicity of Docetaxel Loaded Estradiol Functionalized Stealth Polymeric Nanoparticles

(2015) Sanyog Jain et al.   MOLECULAR PHARMACEUTICS

Co-delivery of Pirarubicin and Paclitaxel by Human Serum Albumin Nanoparticles to Enhance Antitumor Effect and Reduce Systemic Toxicity in Breast Cancers

(2015) Xiaoli Yi et al.   MOLECULAR PHARMACEUTICS

SPARC

(2015) Juan Vaz et al.   PANCREAS

Quercetin Reduces Ehrlich Tumor-Induced Cancer Pain in Mice

(2015) Cassia Calixto-Campos et al.   Analytical Cellular Pathology

Abraxane, the Nanoparticle Formulation of Paclitaxel Can Induce Drug Resistance by Up-Regulation of P-gp

(2015) Minzhi Zhao et al.   PLoS One

Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles

(2014) Shougang Jiang et al.   DRUG DELIVERY

Nanoways to overcome docetaxel resistance in prostate cancer

(2014) Aditya Ganju et al.   DRUG RESISTANCE UPDATES

Novel self-nanoemulsifying formulation of quercetin: Implications of pro-oxidant activity on the anticancer efficacy

(2014) Amit K. Jain et al.   Nanomedicine-Nanotechnology Biology and Medicine

Combinatorial bio-conjugation of gemcitabine and curcumin enables dual drug delivery with synergistic anticancer efficacy and reduced toxicity

(2014) Sanyog Jain et al.   RSC Advances

Treatment innovations for metastatic breast cancer: Nanoparticle albumin-bound (NAB) technology targeted to tumors

(2013) Ana Lluch et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

How nanotechnology can enhance docetaxel therapy

(2013) Na Zhang et al.   International Journal of Nanomedicine

Co-encapsulation of Tamoxifen and Quercetin in Polymeric Nanoparticles: Implications on Oral Bioavailability, Antitumor Efficacy, and Drug-Induced Toxicity

(2013) Amit K. Jain et al.   MOLECULAR PHARMACEUTICS

Effects of quercetin on the proliferation of breast cancer cells and expression of survivin in vitro

(2013) XIAO-HUI DENG et al.   Experimental and Therapeutic Medicine

Current development in nanoformulations of docetaxel

(2012) Qi Tan et al.   Expert Opinion on Drug Delivery

Nanoparticle Delivery of Cancer Drugs

(2011) Andrew Z. Wang et al.   Annual Review of Medicine

Albumin-based nanoparticles as potential controlled release drug delivery systems

(2011) Ahmed O. Elzoghby et al.   JOURNAL OF CONTROLLED RELEASE

Quercetin: A potential drug to reverse multidrug resistance

(2010) Chen Chen et al.   LIFE SCIENCES

Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance

(2009) Yogesh Patil et al.   JOURNAL OF CONTROLLED RELEASE

Nanoparticle Albumin - Bound (NAB) Technology is a Promising Method for Anti-Cancer Drug Delivery

(2009) Qiang Fu et al.   Recent Patents on Anti-Cancer Drug Discovery

Protein nanoparticles as drug carriers in clinical medicine

(2008) Michael J. Hawkins et al.   ADVANCED DRUG DELIVERY REVIEWS

Preparation, Characterization and In Vitro Evaluation of Solid Dispersions Containing Docetaxel

(2008) Jie Chen et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

The antioxidant properties of serum albumin

(2008) Marjolaine Roche et al.   FEBS LETTERS

Effects of low dose quercetin: Cancer cell-specific inhibition of cell cycle progression

(2008) Jae-Hoon Jeong et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Method for Analysis of Nanoparticle Hemolytic Properties in Vitro

(2008) Marina A. Dobrovolskaia et al.   NANO LETTERS

Naringenin Enhances the Anti-Tumor Effect of Doxorubicin Through Selectively Inhibiting the Activity of Multidrug Resistance-Associated Proteins but not P-glycoprotein

(2008) Fa Yun Zhang et al.   PHARMACEUTICAL RESEARCH